Clinicopathological features and survival disparities between axial and appendicular skeletal Angiosarcoma: A SEER-based analysis using competing risk models
Authors:
Open Access
- 22 January 2026
- journal article
- Published by Elsevier in Journal of Bone Oncology
- Vol. 57, 100740
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Clinicopathologic and Molecular Analysis of Primary Angiosarcoma of Bone—A Single Institution ExperienceGenes, Chromosomes and Cancer, 2025
- Stereotactic Body and Conventional Radiotherapy for Painful Bone MetastasesJAMA Network Open, 2024
- Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS)Scientific Reports, 2020
- Current and Future Directions for Angiosarcoma TherapyCurrent Treatment Options in Oncology, 2018
- A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like familiesNature Communications, 2015
- Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyEuropean Journal of Cancer, 2015
- PrefaceCancer, 2014
- A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functionsJournal of Clinical Epidemiology, 2013
- Consistent MYC and FLT4 gene amplification in radiation‐induced angiosarcoma but not in other radiation‐associated atypical vascular lesionsGenes, Chromosomes and Cancer, 2010
- Localized Ewing's sarcoma of bone: Ten years' experience at the Istituto Ortopedico Rizzoli in 124 cases treated with multimodal therapyEuropean Journal of Cancer and Clinical Oncology, 1985